These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4413508)
21. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: correlation with clinical profiles and neurochemistry. Mandybur GT; Miyagi Y; Yin W; Perkins E; Zhang JH Neurol Res; 2003 Jan; 25(1):104-11. PubMed ID: 12564136 [TBL] [Abstract][Full Text] [Related]
23. [Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease]. da Costa AG; Gago MF; Garrett C Acta Med Port; 2011 Dec; 24 Suppl 4():761-8. PubMed ID: 22863482 [TBL] [Abstract][Full Text] [Related]
24. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies. Stuendl A; Kunadt M; Kruse N; Bartels C; Moebius W; Danzer KM; Mollenhauer B; Schneider A Brain; 2016 Feb; 139(Pt 2):481-94. PubMed ID: 26647156 [TBL] [Abstract][Full Text] [Related]
25. The free amino acids in adult human cerebrospinal fluid. Fisher RG; Pomeroy J; Henry JP Acta Neurol Scand; 1968; 44(5):619-30. PubMed ID: 5726734 [No Abstract] [Full Text] [Related]
26. 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis. Lewitt PA; Li J; Lu M; Beach TG; Adler CH; Guo L; Mov Disord; 2013 Oct; 28(12):1653-60. PubMed ID: 23873789 [TBL] [Abstract][Full Text] [Related]
27. Quantitative two-dimensional chromatography for free amino acids in cerebrospinal fluid analysis. A detailed description of method and further observations in normal cerebrospinal fluid. LOGOTHETIS J; BOVIS M World Neurol; 1961 Sep; 2():747-61. PubMed ID: 13763182 [No Abstract] [Full Text] [Related]
28. Cerebrospinal fluid choline levels are decreased in Parkinson's disease. Manyam BV; Giacobini E; Colliver JA Ann Neurol; 1990 Jun; 27(6):683-5. PubMed ID: 2360805 [TBL] [Abstract][Full Text] [Related]
29. [Chromatography of free amino acids in normal cerebrospinal fluid in man]. KEMALI D; PORCELLATI G Boll Soc Ital Biol Sper; 1952 Jun; 28(6):1275-7. PubMed ID: 13018728 [No Abstract] [Full Text] [Related]
30. TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Vawter MP; Dillon-Carter O; Tourtellotte WW; Carvey P; Freed WJ Exp Neurol; 1996 Dec; 142(2):313-22. PubMed ID: 8934562 [TBL] [Abstract][Full Text] [Related]
31. Ferritin in the cerebrospinal fluid of patients with Parkinson's disease. Pall HS; Brailsford S; Williams AC; Lunec J; Blake DR J Neurol Neurosurg Psychiatry; 1990 Sep; 53(9):803. PubMed ID: 2246663 [No Abstract] [Full Text] [Related]
32. Cerebrospinal fluid choline levels in Parkinson's disease. Nasr A; Bertrand N; Giroud M; Septien L; Gras P; Dumas R; Beley A; Bralet J Ann Neurol; 1993 Jul; 34(1):114-5. PubMed ID: 8517672 [No Abstract] [Full Text] [Related]
33. Parkinson's disease and benign essential tremor: somatostatin-like immunoreactivity in the cerebrospinal fluid. Christensen SE; Dupont E; Mondrup K; Olivarius BF; Orskov H Adv Neurol; 1984; 40():325-31. PubMed ID: 6229980 [No Abstract] [Full Text] [Related]
34. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy. Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192 [No Abstract] [Full Text] [Related]
35. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in Parkinsonian cerebrospinal fluid. Maruyama W; Abe T; Tohgi H; Dostert P; Naoi M Ann Neurol; 1996 Jul; 40(1):119-22. PubMed ID: 8687181 [TBL] [Abstract][Full Text] [Related]
36. [Normal range of free amino acids in cerebrospinal fluid of children (author's transl)]. Liappis N; Jäkel A; Bantzer P Klin Padiatr; 1977 Mar; 189(2):155-60. PubMed ID: 558469 [TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Parkinson's disease. Molina JA; de Bustos F; Jiménez-Jiménez FJ; Benito-León J; Ortí-Pareja M; Gasalla T; Tallón-Barranco A; Navarro JA; Arenas J; Enríquez-de-Salamanca R J Neural Transm (Vienna); 1997; 104(11-12):1287-93. PubMed ID: 9503274 [TBL] [Abstract][Full Text] [Related]
38. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
39. A cerebrospinal fluid turnover in Parkinson's disease. Jamrozik Z; Królicki L; Kwieciński H; Florek M Mater Med Pol; 1996; 28(3):79-82. PubMed ID: 9167416 [TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid arginine vasopressin in Parkinson's disease, dementia, and other degenerative disorders. Olsson JE; Forsling ML; Lindvall B; Akerlund M Adv Neurol; 1987; 45():239-42. PubMed ID: 3825696 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]